Beranda › Skleroderma Difus › Michigan › Ann Arbor
Uji klinis Skleroderma Difus di Ann Arbor, MI
7 studi untuk Skleroderma Difus mencari peserta di lokasi sekitar Ann Arbor (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Menerima pesertaFase 2
- Uni Of Michigan Health System, Ann Arbor
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Menerima pesertaFase 2/3
- GSK Investigational Site, Ann Arbor
Platform Clinical Study for Conquering Scleroderma
Menerima pesertaFase 2
- University of Michigan, Ann Arbor
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Menerima pesertaFase 2/3
- University of Michigan, Ann Arbor
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Menerima pesertaFase 1/2
- Nkarta Investigational Site, Ann Arbor
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Menerima pesertaFase 2
- Galderma Investigational Site # 8743, Ann Arbor
The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
Menerima peserta
- University of Michigan, Ann Arbor
Uji klinis Skleroderma Difus di kota lain
- New York City, NY8 studi
- Chicago, IL7 studi
- Durham, NC6 studi
- Los Angeles, CA6 studi
- Baltimore, MD5 studi
- Houston, TX5 studi
- Boston, MA5 studi
- Pittsburgh, PA4 studi
- Kansas City, KS4 studi
- New Orleans, LA4 studi
- Philadelphia, PA4 studi
- Aurora, CO3 studi
Studi lain di Ann Arbor
- Kanker Prostat27 studi
- Kanker Payudara26 studi
- Kanker Paru Non-Sel Kecil26 studi
- Kanker (semua jenis)25 studi
- Kanker Kolorektal23 studi
- Kanker Paru23 studi
- Gagal Jantung22 studi
- Leukemia Mieloid Akut17 studi
- Penyakit Kardiovaskular16 studi
- Kanker Pankreas14 studi
- Kanker Ginjal (Karsinoma Sel Renal)12 studi
- Melanoma12 studi
Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.